T. Delovitch

Decreased renal ischemia-reperfusion injury by IL-16 inactivation.

A. Jevnikar, C. Du, W. Cruikshank, 2008, Kidney international.

Structure‐guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non‐obese diabetic mice

S. Haeryfar, P. Savage, T. Delovitch, 2011, Clinical and experimental immunology.

Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes

S. Haeryfar, S. Porcelli, N. Veerapen, 2011, Clinical and experimental immunology.

An α‐galactosylceramide C20:2 N‐acyl variant enhances anti‐inflammatory and regulatory T cell‐independent responses that prevent type 1 diabetes

S. Porcelli, N. Veerapen, B. Rubin, 2009, Clinical and experimental immunology.

The role of H-2 and Ia antigens in graft-versus-host reactions (GVHR). Presence of host alloantigens on donor cells after GVHR and suppression of GVHR with an anti-Ia antiserum against hose Ia antigens

G. Prud’homme, T. Delovitch, U. Sohn, 1979, The Journal of experimental medicine.

Graft-vs-host reactions induce H-2 class II gene transcription in host kidney cells

P. Halloran, G. Sinclair, A. Wadgymar, 2004, Immunogenetics.

In vitro analysis of allogeneic lymphocyte interaction. I. Characterization and cellular origin of an Ia-positive helper factor- allogeneic effect factor

H. McDevitt, T. Delovitch, 1977, The Journal of experimental medicine.

Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice.

J. Petrik, D. Hill, T. McDonald, 1999, The Journal of endocrinology.